Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
| Period Ending | 2021-11-30 | 2022-11-30 | 2023-11-30 | 2024-11-30 | 2025-11-30 | |
|---|---|---|---|---|---|---|
| Revenue | $6.3B | $6.4B | $6.7B | $6.7B | $6.8B | |
| Revenue Growth (YoY) | 12.79% | 0.52% | 4.91% | 0.92% | 1.73% | |
| Cost of Revenues | $3.8B | $4.1B | $4.2B | $4.1B | $4.2B | |
| Gross Profit | $2.5B | $2.3B | $2.5B | $2.6B | $2.6B | |
| Gross Profit Margin | 39.67% | 35.79% | 37.56% | 38.51% | 37.91% | |
| R&D Expenses | $87.3M | $87.5M | $94.9M | $102.9M | $106.1M | |
| Selling, General & Admin | $1.4B | $1.4B | $1.5B | $1.5B | $1.5B | |
| Other Inc / (Exp) | -$67.4M | $26.7M | -$53.9M | -$8M | -- | |
| Operating Expenses | $1.4B | $1.4B | $1.5B | $1.5B | $1.5B | |
| Operating Income | $1.1B | $915.8M | $1B | $1.1B | $1.1B | |
| Net Interest Expenses | $146.8M | $179.6M | $201.8M | $189.1M | $181.5M | |
| EBT. Incl. Unusual Items | $895.8M | $812.8M | $798.7M | $898.3M | $913M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $192.7M | $168.6M | $174.5M | $184M | $195.8M | |
| Net Income to Company | $755.3M | $682M | $680.6M | $788.5M | $789.4M | |
| Minority Interest in Earnings | -- | -- | -$5.5M | -$7.5M | -- | |
| Net Income to Common Excl Extra Items | $755.3M | $682M | $675.1M | $781M | $789.4M | |
| Basic EPS (Cont. Ops) | $2.83 | $2.54 | $2.54 | $2.94 | $2.94 | |
| Diluted EPS (Cont. Ops) | $2.80 | $2.52 | $2.52 | $2.92 | $2.93 | |
| Weighted Average Basic Share | $267.3M | $268.2M | $268.4M | $268.5M | $268.5M | |
| Weighted Average Diluted Share | $269.9M | $270.2M | $269.8M | $269.6M | $269.4M | |
| EBITDA | $1.3B | $1.1B | $1.2B | $1.3B | $1.3B | |
| EBIT | $1.1B | $915.8M | $1B | $1.1B | $1.1B | |
| Revenue (Reported) | $6.3B | $6.4B | $6.7B | $6.7B | $6.8B | |
| Operating Income (Reported) | $1.1B | $915.8M | $1B | $1.1B | $1.1B | |
| Operating Income (Adjusted) | $1.1B | $915.8M | $1B | $1.1B | $1.1B | |
| Period Ending | 2021-11-30 | 2022-11-30 | 2023-11-30 | 2024-11-30 | 2025-11-30 | |
|---|---|---|---|---|---|---|
| Revenue | $1.7B | $1.7B | $1.8B | $1.8B | $1.9B | |
| Revenue Growth (YoY) | 11.07% | -2% | 3.37% | 2.58% | 2.91% | |
| Cost of Revenues | $1B | $1.1B | $1.1B | $1.1B | $1.1B | |
| Gross Profit | $707.7M | $623.5M | $702M | $722.5M | $720.8M | |
| Gross Profit Margin | 40.9% | 36.77% | 40.05% | 40.18% | 38.95% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $398.9M | $346.5M | $390M | $414.4M | $404.8M | |
| Other Inc / (Exp) | -$20.6M | -$3.8M | -$37.5M | -$36.8M | -- | |
| Operating Expenses | $398.9M | $346.5M | $390M | $414.4M | $404.8M | |
| Operating Income | $308.8M | $277M | $312M | $308.1M | $316M | |
| Net Interest Expenses | $35.9M | $65M | $49.8M | $48.3M | $46.3M | |
| EBT. Incl. Unusual Items | $248.2M | $228.3M | $257.7M | $264.2M | $274M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $57.2M | $53.2M | $57.1M | $67.2M | $65.6M | |
| Net Income to Company | $197.4M | $185.7M | $219.3M | $215.2M | $226.6M | |
| Minority Interest in Earnings | -- | -- | -$2M | -$1.5M | -- | |
| Net Income to Common Excl Extra Items | $197.4M | $185.7M | $217.3M | $213.7M | $226.6M | |
| Basic EPS (Cont. Ops) | $0.74 | $0.69 | $0.82 | $0.80 | $0.84 | |
| Diluted EPS (Cont. Ops) | $0.73 | $0.69 | $0.81 | $0.80 | $0.84 | |
| Weighted Average Basic Share | $267.4M | $268.3M | $268.4M | $268.4M | $268.6M | |
| Weighted Average Diluted Share | $269.9M | $269.9M | $269.6M | $269.7M | $269.3M | |
| EBITDA | $356M | $329.4M | $360.9M | $359.4M | $375.2M | |
| EBIT | $308.8M | $277M | $312M | $308.1M | $316M | |
| Revenue (Reported) | $1.7B | $1.7B | $1.8B | $1.8B | $1.9B | |
| Operating Income (Reported) | $308.8M | $277M | $312M | $308.1M | $316M | |
| Operating Income (Adjusted) | $308.8M | $277M | $312M | $308.1M | $316M | |
| Period Ending | 2021-11-30 | 2022-11-30 | 2023-11-30 | 2024-11-30 | 2025-11-30 | |
|---|---|---|---|---|---|---|
| Revenue | $6.3B | $6.4B | $6.7B | $6.7B | $6.8B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $3.8B | $4.1B | $4.2B | $4.1B | $4.2B | |
| Gross Profit | $2.5B | $2.3B | $2.5B | $2.6B | $2.6B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.4B | $1.4B | $1.5B | $1.5B | $1.5B | |
| Other Inc / (Exp) | -$60.1M | $38.9M | -$53.9M | -$8M | -- | |
| Operating Expenses | $1.4B | $1.4B | $1.5B | $1.5B | $1.5B | |
| Operating Income | $1.1B | $915.8M | $1B | $1.1B | $1.1B | |
| Net Interest Expenses | $146.1M | $179.6M | $196.3M | $199.5M | $206.5M | |
| EBT. Incl. Unusual Items | $895.8M | $812.8M | $798.7M | $898.3M | $913M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $192.7M | $168.6M | $174.5M | $184M | $195.8M | |
| Net Income to Company | $755.3M | $682M | $680.6M | $788.5M | $789.4M | |
| Minority Interest in Earnings | -- | -- | -$2M | -$1.5M | -- | |
| Net Income to Common Excl Extra Items | $755.3M | $682M | $678.6M | $787M | $789.4M | |
| Basic EPS (Cont. Ops) | $2.83 | $2.54 | $2.54 | $2.94 | $2.94 | |
| Diluted EPS (Cont. Ops) | $2.80 | $2.52 | $2.52 | $2.92 | $2.93 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $1.3B | $1.1B | $1.2B | $1.3B | $1.3B | |
| EBIT | $1.1B | $915.8M | $1B | $1.1B | $1.1B | |
| Revenue (Reported) | $6.3B | $6.4B | $6.7B | $6.7B | $6.8B | |
| Operating Income (Reported) | $1.1B | $915.8M | $1B | $1.1B | $1.1B | |
| Operating Income (Adjusted) | $1.1B | $915.8M | $1B | $1.1B | $1.1B | |
| Period Ending | 2022-11-30 | 2023-11-30 | 2024-11-30 | 2025-11-30 | 2026-11-30 | |
|---|---|---|---|---|---|---|
| Revenue | $6.4B | $6.7B | $6.7B | $6.8B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $4.1B | $4.2B | $4.1B | $4.2B | -- | |
| Gross Profit | $2.3B | $2.5B | $2.6B | $2.6B | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.4B | $1.5B | $1.5B | $1.5B | -- | |
| Other Inc / (Exp) | $38.9M | -$53.9M | -$8M | $6.8M | -- | |
| Operating Expenses | $1.4B | $1.5B | $1.5B | $1.5B | -- | |
| Operating Income | $915.8M | $1B | $1.1B | $1.1B | -- | |
| Net Interest Expenses | $179.6M | $196.3M | $199.5M | $206.5M | -- | |
| EBT. Incl. Unusual Items | $812.8M | $798.7M | $898.3M | $913M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $168.6M | $174.5M | $184M | $195.8M | -- | |
| Net Income to Company | $682M | $680.6M | $788.5M | $789.4M | -- | |
| Minority Interest in Earnings | -- | -$2M | -$1.5M | -- | -- | |
| Net Income to Common Excl Extra Items | $682M | $678.6M | $787M | $789.4M | -- | |
| Basic EPS (Cont. Ops) | $2.54 | $2.54 | $2.94 | $2.94 | -- | |
| Diluted EPS (Cont. Ops) | $2.52 | $2.52 | $2.92 | $2.93 | -- | |
| Weighted Average Basic Share | $1.1B | $1.1B | $1.1B | $1.1B | -- | |
| Weighted Average Diluted Share | $1.1B | $1.1B | $1.1B | $1.1B | -- | |
| EBITDA | $1.1B | $1.2B | $1.3B | $1.3B | -- | |
| EBIT | $915.8M | $1B | $1.1B | $1.1B | -- | |
| Revenue (Reported) | $6.4B | $6.7B | $6.7B | $6.8B | -- | |
| Operating Income (Reported) | $915.8M | $1B | $1.1B | $1.1B | -- | |
| Operating Income (Adjusted) | $915.8M | $1B | $1.1B | $1.1B | -- | |
| Period Ending | 2021-11-30 | 2022-11-30 | 2023-11-30 | 2024-11-30 | 2025-11-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $351.7M | $334M | $166.6M | $186.1M | $95.9M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $549.5M | $573.7M | $587.5M | $587.4M | $628.9M | |
| Inventory | $1.2B | $1.3B | $1.1B | $1.2B | $1.3B | |
| Prepaid Expenses | $41.7M | $61.7M | $47.6M | $51.5M | $53.2M | |
| Other Current Assets | $70.6M | $77.2M | $73.4M | $74.1M | -- | |
| Total Current Assets | $2.2B | $2.4B | $2B | $2.1B | $2.1B | |
| Property Plant And Equipment | $1.4B | $1.6B | $1.7B | $1.8B | $1.9B | |
| Long-Term Investments | $301.3M | $283M | $264.1M | $282.7M | $300.7M | |
| Goodwill | $5.3B | $5.2B | $5.3B | $5.2B | -- | |
| Other Intangibles | $3.6B | $3.5B | $3.5B | $3.5B | -- | |
| Other Long-Term Assets | $140.6M | $153.4M | $148.1M | $176.7M | -- | |
| Total Assets | $12.9B | $13.1B | $12.9B | $13.1B | $13.2B | |
| Accounts Payable | $1.1B | $1.2B | $1.1B | $1.2B | $1.3B | |
| Accrued Expenses | $751.2M | $649.5M | $795.5M | $775.7M | -- | |
| Current Portion Of Long-Term Debt | $778.6M | $282.7M | $802.1M | $317M | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $3.2B | $3.4B | $3.1B | $2.9B | $3.1B | |
| Long-Term Debt | $4.1B | $3.8B | $3.5B | $3.8B | $3.3B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $8.5B | $8.4B | $7.8B | $7.8B | $7.4B | |
| Common Stock | $2.1B | $2.1B | $2.2B | $2.2B | $2.3B | |
| Other Common Equity Adj | -$426.5M | -$480.6M | -$388.6M | -$491.2M | -- | |
| Common Equity | $4.4B | $4.7B | $5.1B | $5.3B | $5.7B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $14.5M | $18.7M | $22.8M | $25.8M | $31.6M | |
| Total Equity | $4.4B | $4.7B | $5.1B | $5.3B | $5.8B | |
| Total Liabilities and Equity | $12.9B | $13.1B | $12.9B | $13.1B | $13.2B | |
| Cash and Short Terms | $351.7M | $334M | $166.6M | $186.1M | $95.9M | |
| Total Debt | $4.8B | $4.1B | $4.3B | $4B | $3.8B | |
| Period Ending | 2021-11-30 | 2022-11-30 | 2023-11-30 | 2024-11-30 | 2025-11-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $351.7M | $334M | $166.6M | $186.1M | $95.9M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $549.5M | $573.7M | $587.5M | $587.4M | $628.9M | |
| Inventory | $1.2B | $1.3B | $1.1B | $1.2B | $1.3B | |
| Prepaid Expenses | $41.7M | $61.7M | $47.6M | $51.5M | $53.2M | |
| Other Current Assets | $70.6M | $77.2M | $73.4M | $74.1M | -- | |
| Total Current Assets | $2.2B | $2.4B | $2B | $2.1B | $2.1B | |
| Property Plant And Equipment | $1.4B | $1.6B | $1.7B | $1.8B | $1.9B | |
| Long-Term Investments | $301.3M | $283M | $264.1M | $282.7M | $300.7M | |
| Goodwill | $5.3B | $5.2B | $5.3B | $5.2B | -- | |
| Other Intangibles | $3.6B | $3.5B | $3.5B | $3.5B | -- | |
| Other Long-Term Assets | $140.6M | $153.4M | $148.1M | $176.7M | -- | |
| Total Assets | $12.9B | $13.1B | $12.9B | $13.1B | $13.2B | |
| Accounts Payable | $1.1B | $1.2B | $1.1B | $1.2B | $1.3B | |
| Accrued Expenses | $751.2M | $649.5M | $795.5M | $775.7M | -- | |
| Current Portion Of Long-Term Debt | $778.6M | $282.7M | $802.1M | $317M | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $3.2B | $3.4B | $3.1B | $2.9B | $3.1B | |
| Long-Term Debt | $4.1B | $3.8B | $3.5B | $3.8B | $3.3B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $8.5B | $8.4B | $7.8B | $7.8B | $7.4B | |
| Common Stock | $2.1B | $2.1B | $2.2B | $2.2B | $2.3B | |
| Other Common Equity Adj | -$426.5M | -$480.6M | -$388.6M | -$491.2M | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $14.5M | $18.7M | $22.8M | $25.8M | $31.6M | |
| Total Equity | $4.4B | $4.7B | $5.1B | $5.3B | $5.8B | |
| Total Liabilities and Equity | $12.9B | $13.1B | $12.9B | $13.1B | $13.2B | |
| Cash and Short Terms | $351.7M | $334M | $166.6M | $186.1M | $95.9M | |
| Total Debt | $4.8B | $4.1B | $4.3B | $4B | $3.8B | |
| Period Ending | 2021-11-30 | 2022-11-30 | 2023-11-30 | 2024-11-30 | 2025-11-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $755.3M | $682M | $680.6M | $788.5M | $789.4M | |
| Depreciation & Amoritzation | $186.3M | $200.6M | $199.3M | $208.8M | $231.3M | |
| Stock-Based Compensation | $66.6M | $60.3M | $63.4M | $47.4M | $46.2M | |
| Change in Accounts Receivable | -$22.6M | -$45.8M | $3.4M | -$20.5M | -$14.7M | |
| Change in Inventories | -$153.7M | -$205.3M | $225M | -$125M | $23.9M | |
| Cash From Operations | $828.3M | $651.5M | $1.2B | $921.9M | $962.2M | |
| Capital Expenditures | $278M | $262M | $263.9M | $274.9M | $221.8M | |
| Cash Acquisitions | $706.4M | -- | -- | -- | $34.1M | |
| Cash From Investing | -$908.6M | -$146.4M | -$260.5M | -$269M | -$255.2M | |
| Dividends Paid (Ex Special Dividend) | $363.3M | $396.7M | $418.5M | $451M | $483M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1B | -- | $496.4M | $495.5M | -- | |
| Long-Term Debt Repaid | -$257.1M | -$772M | -$268.1M | -$801.1M | -- | |
| Repurchase of Common Stock | $8.6M | $38.8M | $35.7M | $53.1M | $34.8M | |
| Other Financing Activities | -$17.3M | -$19.4M | -$10.3M | -$2M | -- | |
| Cash From Financing | $22M | -$487.2M | -$1.2B | -$583.1M | -$840.9M | |
| Beginning Cash (CF) | $351.7M | $334M | $166.6M | $186.1M | $95.9M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$71.9M | -$17.7M | -$167.4M | $19.5M | -$90.2M | |
| Ending Cash (CF) | $266.2M | $280.7M | $39.2M | $155.3M | $49.4M | |
| Levered Free Cash Flow | $550.3M | $389.5M | $973.4M | $647M | $740.4M | |
| Period Ending | 2021-11-30 | 2022-11-30 | 2023-11-30 | 2024-11-30 | 2025-11-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $197.4M | $185.7M | $219.3M | $215.2M | $226.6M | |
| Depreciation & Amoritzation | $47.2M | $52.4M | $48.9M | $51.3M | $59.2M | |
| Stock-Based Compensation | $12.4M | $11.2M | $12.3M | $7.5M | $8.9M | |
| Change in Accounts Receivable | -$23.9M | -$2.2M | $26.3M | $51.7M | $37.2M | |
| Change in Inventories | $2.8M | $33.2M | $85.3M | -$16.1M | $49.9M | |
| Cash From Operations | $455.4M | $401.4M | $577.2M | $458.7M | $542M | |
| Capital Expenditures | $88.1M | $95.2M | $76.7M | $85.6M | $83.7M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$78M | -$90.9M | -$75.7M | -$79.9M | -$83M | |
| Dividends Paid (Ex Special Dividend) | $90.9M | $99.2M | $104.7M | $112.7M | $120.8M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | $495.5M | -- | |
| Long-Term Debt Repaid | -$1.8M | -$3.3M | -$255.4M | -$48.3M | -- | |
| Repurchase of Common Stock | $5.4M | $12.7M | $9M | $24.1M | $5.6M | |
| Other Financing Activities | -$2.1M | -- | -- | $5.2M | -- | |
| Cash From Financing | -$325M | -$313.5M | -$483M | -$377.2M | -$462.6M | |
| Beginning Cash (CF) | $351.7M | $334M | $166.6M | $186.1M | $95.9M | |
| Foreign Exchange Rate Adjustment | -$13.3M | -$6.9M | -$6.6M | -$16.3M | $4.6M | |
| Additions / Reductions | $39.1M | -$9.9M | $11.9M | -$14.7M | $1M | |
| Ending Cash (CF) | $377.5M | $317.2M | $171.9M | $155.1M | $101.5M | |
| Levered Free Cash Flow | $367.3M | $306.2M | $500.5M | $373.1M | $458.3M | |
| Period Ending | 2021-11-30 | 2022-11-30 | 2023-11-30 | 2024-11-30 | 2025-11-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $755.3M | $682M | $680.6M | $788.5M | $789.4M | |
| Depreciation & Amoritzation | $186.3M | $200.6M | $199.3M | $208.8M | $231.3M | |
| Stock-Based Compensation | $66.6M | $60.3M | $63.4M | $47.4M | $46.2M | |
| Change in Accounts Receivable | -- | -$45.8M | $3.4M | -$20.5M | -$14.7M | |
| Change in Inventories | -- | -$205.3M | $225M | -$125M | $23.9M | |
| Cash From Operations | $828.3M | $651.5M | $1.2B | $921.9M | $962.2M | |
| Capital Expenditures | $278M | $262M | $263.9M | $274.9M | $221.8M | |
| Cash Acquisitions | $706.4M | -- | -- | -- | $34.1M | |
| Cash From Investing | -$908.6M | -$146.4M | -$260.5M | -$269M | -$255.2M | |
| Dividends Paid (Ex Special Dividend) | $363.3M | $396.7M | $418.5M | $451M | $483M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1B | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$257.1M | -$772M | -$268.1M | -$801.1M | -- | |
| Repurchase of Common Stock | $8.6M | $38.8M | $35.7M | $53.1M | $34.8M | |
| Other Financing Activities | -$17.3M | -$19.4M | -$10.3M | -$2M | -- | |
| Cash From Financing | $22M | -$487.2M | -$1.2B | -$583.1M | -$840.9M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$71.9M | -$17.7M | -$167.4M | $19.5M | -$90.2M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $550.3M | $389.5M | $973.4M | $647M | $740.4M | |
| Period Ending | 2022-11-30 | 2023-11-30 | 2024-11-30 | 2025-11-30 | 2026-11-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $682M | $680.6M | $788.5M | $789.4M | -- | |
| Depreciation & Amoritzation | $200.6M | $199.3M | $208.8M | $231.3M | -- | |
| Stock-Based Compensation | $60.3M | $63.4M | $47.4M | $46.2M | -- | |
| Change in Accounts Receivable | -$45.8M | $3.4M | -$20.5M | -$14.7M | -- | |
| Change in Inventories | -$205.3M | $225M | -$125M | $23.9M | -- | |
| Cash From Operations | $651.5M | $1.2B | $921.9M | $962.2M | -- | |
| Capital Expenditures | $262M | $263.9M | $274.9M | $221.8M | -- | |
| Cash Acquisitions | -- | -- | -- | $34.1M | -- | |
| Cash From Investing | -$146.4M | -$260.5M | -$269M | -$255.2M | -- | |
| Dividends Paid (Ex Special Dividend) | $396.7M | $418.5M | $451M | $483M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $496.4M | $495.5M | $900K | -- | |
| Long-Term Debt Repaid | -$772M | -$268.1M | -$801.1M | -$13.6M | -- | |
| Repurchase of Common Stock | $38.8M | $35.7M | $53.1M | $34.8M | -- | |
| Other Financing Activities | -$19.4M | -$10.3M | -$2M | $8.5M | -- | |
| Cash From Financing | -$487.2M | -$1.2B | -$583.1M | -$840.9M | -- | |
| Beginning Cash (CF) | $1.3B | $805.5M | $731.2M | $417.7M | -- | |
| Foreign Exchange Rate Adjustment | -$35.6M | $40M | -$50.3M | $43.7M | -- | |
| Additions / Reductions | -$17.7M | -$167.4M | $19.5M | -$90.2M | -- | |
| Ending Cash (CF) | $1.3B | $678.1M | $700.4M | $371.2M | -- | |
| Levered Free Cash Flow | $389.5M | $973.4M | $647M | $740.4M | -- | |
Signup to receive the latest stock alerts
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Though certainly less well-known than the huge tech businesses that…
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Market Cap: $4.6T
P/E Ratio: 65x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 29x
Teradata Corp. [TDC] is down 11.64% over the past day.
Diodes, Inc. [DIOD] is down 7.63% over the past day.
Vertiv Holdings Co. [VRT] is down 4.79% over the past day.